Supplementary Table 2 from NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion
Authors:
- Katelyn J. NoronhaKNKatelyn J. Noronha
- Karlie N. LucasKLKarlie N. Lucas
- Sateja ParadkarSPSateja Paradkar
- Joseph EdmondsJEJoseph Edmonds
- Sam FriedmanSFSam Friedman
- Matthew A. MurrayMMMatthew A. Murray
- Samantha LiuSLSamantha Liu
- Dipti P. SajedDSDipti P. Sajed
- Chana SachsCSChana Sachs
- Josh SpurrierJSJosh Spurrier
- Mitch RaponiMRMitch Raponi
- Jiayu LiangJLJiayu Liang
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)